JPH10158197A - リンパ管造影コントラスト媒体 - Google Patents

リンパ管造影コントラスト媒体

Info

Publication number
JPH10158197A
JPH10158197A JP9103416A JP10341697A JPH10158197A JP H10158197 A JPH10158197 A JP H10158197A JP 9103416 A JP9103416 A JP 9103416A JP 10341697 A JP10341697 A JP 10341697A JP H10158197 A JPH10158197 A JP H10158197A
Authority
JP
Japan
Prior art keywords
contrast
molecular weight
imaging
water
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP9103416A
Other languages
English (en)
Japanese (ja)
Inventor
Gregory L Mcintyre
エル． マッキンタイヤー，グレゴリー
David L Rado
エル． ラド，デイヴィド
Edward R Bacon
アール． ベイコン，エドワード
John L Tonner
エル． トナー，ジョン
George C Naa
シー．［理由書］ 本件特許出願に関し、発明者の「住所又は居所」の欄において「米国 ペンシルバニア州 １９０８７−８６３０，ウェイン，デーボン パーク ドライブ ４６６ ニコムド アイエヌシー．内」と記載すべきところ、「米国 ペンシルバニア州 １９０８７−８６３０，ウェイン，パークドライヴ ４６６」で出願いたしました。これは錯誤によるものですので、発明者の「住所又は居所」の欄を訂正致します。 ナー，ジョージ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of JPH10158197A publication Critical patent/JPH10158197A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP9103416A 1996-11-28 1997-04-21 リンパ管造影コントラスト媒体 Withdrawn JPH10158197A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9624822.4A GB9624822D0 (en) 1996-11-28 1996-11-28 Method
GB9624822:4 1996-11-28

Publications (1)

Publication Number Publication Date
JPH10158197A true JPH10158197A (ja) 1998-06-16

Family

ID=10803662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9103416A Withdrawn JPH10158197A (ja) 1996-11-28 1997-04-21 リンパ管造影コントラスト媒体

Country Status (5)

Country Link
EP (1) EP0941126A1 (fr)
JP (1) JPH10158197A (fr)
AU (1) AU5062198A (fr)
GB (1) GB9624822D0 (fr)
WO (1) WO1998023295A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013133336A (ja) * 2011-12-23 2013-07-08 Central Medical Service Co Ltd 高濃度の造影剤を含み高い造影増強効果を示す造影剤組成物

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166200A (en) * 1995-07-04 2000-12-26 Schering Aktiengesellschaft Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
DE19525924A1 (de) 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
DK1051116T3 (da) * 1998-12-01 2009-02-02 Univ Washington Emboliseringsanordning

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733397A (en) * 1966-12-02 1973-05-15 Pharmacia Ab Method for the x-ray visualization of body cavities and a preparation for carrying out the method
WO1993010824A1 (fr) * 1991-12-04 1993-06-10 Guerbet S.A. Nouveau compose macromoleculaire polyamine iode, son procede de preparation et son utilisation comme agent de contraste
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
EP0654973A4 (fr) * 1992-07-21 1995-08-09 Gen Hospital Corp Systeme d'administration d'un medicament aux tissus lyphatiques.
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging
DE19521940A1 (de) * 1995-06-07 1996-12-12 Schering Ag Iodhaltige lineare Polyamine und Polyamide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013133336A (ja) * 2011-12-23 2013-07-08 Central Medical Service Co Ltd 高濃度の造影剤を含み高い造影増強効果を示す造影剤組成物

Also Published As

Publication number Publication date
AU5062198A (en) 1998-06-22
EP0941126A1 (fr) 1999-09-15
WO1998023295A1 (fr) 1998-06-04
GB9624822D0 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
DE69332952T2 (de) Diagnostische und therapeutische Einheiten enthaltende biokompatible Polymere
JP3315122B2 (ja) ポリアルキレンオキシドに基づくｍｒ像形成組成物
DE69528825T2 (de) Dendrime verbindungen
US5871710A (en) Graft co-polymer adducts of platinum (II) compounds
TW319763B (fr)
EP0436579B1 (fr) Compositions de chelates
JP2894879B2 (ja) 診断用造影剤
EP1960002B1 (fr) Dispersions aqueuses de particules superparamagnetiques monodomaine, leur production et leur utilisation dans le diagnostic et la therapie
JP2002511845A (ja) 造影剤
US5976493A (en) Metabolically cleavable dendrimeric polychelants
JP2007528424A (ja) ヨウ化単量体および二量体の混合物を含むｘ線造影剤製剤
US20020076378A1 (en) Polymers
JPH10158197A (ja) リンパ管造影コントラスト媒体
MXPA06006044A (es) Agentes de contraste.
Zhang et al. The degradation and clearance of Poly (N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent
PL191807B1 (pl) Zastosowanie dożylnych środków kontrastowych do wytwarzania środka diagnostycznego do mammografii projekcyjnej
EP1251875B1 (fr) Utilisation d'agents de contraste dans la fabrication d'agents diagnostiques pour la visualisation de la lumiere intestinale
Bonlawar et al. Targeted Nanotheranostics: Integration of Preclinical MRI and CT in the Molecular Imaging and Therapy of Advanced Diseases
WO1998032469A2 (fr) Polymeres
US20050171424A1 (en) Methods for imaging the lymphatic system using dendrimer-based contrast agents
US20040175329A1 (en) Method for continuous visualization of a body lumen
CA1335819C (fr) Chelate metallique contenant un milieu contrastant pour l'imagerie diagnostique
Younis Synthesis and characterisation of new copolymers for medical imaging visualization of medical device.

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20040706